In a rat model of chemotherapy-induced premature ovarian failure, BM-MSCs reduced luteinizing hormone (LH) and FSH and increased serum estradiol levels compared to the control group (Afifi and Reyad 2013). Here, BRD2 is linked to primary ovarian failure.